Vyzulta Now Approved Website

Dec 1, 2017Nov 30, 2017

Brand: Vyzulta (latanoprostene bunod ophthalmic solution), Drops
Parent Company: Bausch & Lomb
Drug Type: Prescription
Drug Category: Ophthalmology
Campaign: now-approved
Targeting: HCPs
Patient Website: http://www.vyzulta.com
HCP Website: http://www.vyzulta.com/hcp/

: Desktop

: Mobile

: Subscription Confirmation

The gallery of digital pharma marketing screenshots.

Vyzulta Now Approved Website

Your Email

Comments
This field is for validation purposes and should be left unchanged.

We’ll never share or sell your personal info. Ever.